Company Directory - Babson Diagnostics
Company Details - Babson Diagnostics
Babson Diagnostics
WebsiteBabson Diagnostics develops innovative blood testing technology aimed at improving the accessibility and convenience of lab testing for patients.
CCI Score
CCI Score: Babson Diagnostics
60.33
-0.06%
Latest Event
Babson Diagnostics Secures Strategic Investment to Enhance Accessible Blood Testing
Babson Diagnostics announced a strategic investment from BD Partners aimed at accelerating its commercial launch of the BetterWay blood testing service. The initiative is designed to expand access to less invasive, cost‐effective diagnostic testing at local pharmacies, improving the experience and affordability for patients.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
LEADER
Babson Diagnostics is currently rated as a Leader.
Latest Events
- JAN012025
Babson Diagnostics announced a strategic investment from BD Partners aimed at accelerating its commercial launch of the BetterWay blood testing service. The initiative is designed to expand access to less invasive, cost‐effective diagnostic testing at local pharmacies, improving the experience and affordability for patients.
+70
Business Practices and Ethical Responsibility
March 28
The strategic investment reflects a commitment to ethical business practices by channeling funds toward healthcare innovation and improving community access to essential diagnostic services. This move supports marginalized communities by increasing the availability of affordable and less invasive blood testing.
Babson Diagnostics Gains Strategic Investment from BD Partners
+60
Technology and Services Impact
March 28
The investment directly supports technological advancement in healthcare by enabling Babson Diagnostics to deploy its BetterWay blood testing service. This breakthrough minimizes discomfort for patients and increases accessibility to critical diagnostic services, reinforcing positive technological impact.
Babson Diagnostics Gains Strategic Investment from BD Partners
- DEC172024
Babson Diagnostics and BD announced an expansion of their longstanding collaboration to launch an innovative fingertip blood testing technology. The new system uses BD's MiniDraw™ Capillary Blood Collection System combined with Babson's BetterWay technology to simplify blood collection from a patient's finger, thereby increasing access to diagnostic services in underserved and non-traditional healthcare settings.
+60
Technology and Services Impact
March 28
This innovation in blood collection technology enhances healthcare access by enabling efficient testing in diverse, often underserved, environments. By reducing the need for specialized personnel and lowering the barriers to diagnostic testing, Babson Diagnostics and BD are contributing to improved health equity—a key component in supporting marginalized communities and fostering a more inclusive healthcare system.
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
Alternatives
Corporation
0.00
Corporation
0.00
Corporation
0.00
Corporation
-29.37
Fremont, United States
-42.32
Corporation
-39.33
Santa Clara, USA
10.08
Sunnyvale, United States
-32.85
Corporation
5.15
Corporation
0.00
Industries
- 334510
- Electromedical and Electrotherapeutic Apparatus Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511
- Medical Laboratories